Line 8: |
Line 8: |
| #[[Clear cell renal cell carcinoma]] (~65%) | | #[[Clear cell renal cell carcinoma]] (~65%) |
| #Multilocular cystic renal neoplasm of low malignant potential | | #Multilocular cystic renal neoplasm of low malignant potential |
− | #Papillary renal carcinoma (~20%) | + | #[[Papillary renal cell carcinoma]] (~20%) |
| + | ##[[Papillary renal cell carcinoma Type 1 | Type 1]] |
| + | ##[[Papillary renal cell carcinoma Type 2 | Type 2]] |
| #Hereditary leiomyomatosis and renal cell carcinoma (RCC) syndrome–associated RCC | | #Hereditary leiomyomatosis and renal cell carcinoma (RCC) syndrome–associated RCC |
| #[[Chromophobe renal cell carcinoma]] (~5%) | | #[[Chromophobe renal cell carcinoma]] (~5%) |
| #[[Collecting duct carcinoma]] | | #[[Collecting duct carcinoma]] |
| #Renal medullary carcinoma | | #Renal medullary carcinoma |
− | #MiT family translocation carcinomas | + | #[[MiT family translocation carcinomas]] |
| #Succinate dehydrogenase [SDH]–deficient renal carcinomas | | #Succinate dehydrogenase [SDH]–deficient renal carcinomas |
| #Mucinous tubular and spindle cell carcinoma | | #Mucinous tubular and spindle cell carcinoma |